公司資料
Pacific Biosciences 股價、新聞與催化劑
- 股票代碼:
- PACB
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.21 USD (+5.22%)
收盤價
最後更新: 2026年8月17日
491M USD
市值
股價為何變動
As of Aug 17, 2026, PACB closed up 5.22% at $1.21. No new same-company headline was identified in the current news window.
公司概覽
Long-Read Sequencing
Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics. Its HiFi technology reads long DNA fragments while maintaining high base-level accuracy.
Sequencing Platforms
The company's instrument portfolio includes high-throughput Revio systems and benchtop Vega systems. Revenue combines instrument placements with recurring consumables, service and software. PacBio technology is used for whole-genome sequencing, rare-disease analysis, population genomics, microbial research and other applications where resolving structural variation and complex genomic regions is important.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。